Compare Sana Biotechnology Inc (SANA) vs AT&T Inc. (T) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sana Biotechnology Inc vs AT&T Inc. — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while AT&T Inc. trades at $22.3 (market cap $152.52B). The key difference: AT&T Inc. is far larger — about 174.5× Sana Biotechnology Inc's market cap, and AT&T Inc. pays a 5.06% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| SANA | T | |
|---|---|---|
Market Cap | $873.84M | $152.52B |
Sector | Health | Media |
52-Week High | $5.92 | $29.62 |
52-Week Low | $2.68 | $20.49 |
Enterprise Value | $848.03M | $297.87B |
Dividend Yield | — | 5.06% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →About AT&T Inc.
AT&T Inc. is a communications holding company. The Company, through its subsidiaries and affiliates, provides local and long-distance phone service, wireless and data communications, Internet access and messaging, IP-based and satellite television, security services, telecommunications equipment, and directory advertising and publishing.
Read more on T →
